Hamid Zaferani Arani | Biology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Extensive Research Output

    • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos One, Oxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

    • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

  2. Academic and Professional Leadership

    • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

    • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

  3. Conference Participation and Recognition

    • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

    • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

  4. Innovation and Patents

    • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

    • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

  • M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

  • Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

  • President: Ideh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

  • Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

  • Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

  • Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., Hypericin, Naringenin).

  • Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506, Atorvastatin).

  • Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

  • Top National Medical Student (2021)

  • Distinctive Researcher (2016–2020, Islamic Azad University)

  • Best Startup Idea (2019, ITEM Weekend)

  • Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

  • Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
    Year: 2022
    Citations: 115

  • Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
    Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
    Year: 2018
    Citations: 60

  • Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
    Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
    Year: 2020
    Citations: 44

  • Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
    Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
    Year: 2021
    Citations: 30

  • Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
    Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
    Year: 2022
    Citations: 21

  • Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
    Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
    Year: 2020
    Citations: 15

  • Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
    Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
    Year: 2017
    Citations: 15

  • Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
    Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
    Year: 2020
    Citations: 12

  • Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
    Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
    Year: 2020
    Citations: 9

  • Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
    Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
    Year: 2021
    Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.

Hongyong Zhang | Biology | Best Researcher Award

Posted on by Forensic Scientist

Assoc. Prof. Dr. Hongyong Zhang | Biology | Best Researcher Award

Central People’s Hospital of Zhanjiang | China

Dr. Hongyong Zhang is an accomplished Associate Professor at Guangdong Medical University, based at the Central People’s Hospital of Zhanjiang. With an extensive background in developmental biology, molecular reproduction, and gene regulation, he has significantly contributed to the understanding of reproductive mechanisms and genetic engineering. His innovative research, particularly in mammalian oocyte development and gene editing using CRISPR/Cas9, continues to pave the way for breakthroughs in regenerative medicine and reproductive biology.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Strong Academic Background and Postdoctoral Training
    Dr. Zhang has completed his doctoral studies in developmental biology at the Institute of Zoology, Chinese Academy of Sciences, one of China’s premier research institutions, followed by a long postdoctoral tenure until 2019. This foundation indicates deep training in life sciences and developmental biology.

  • Progressive Academic Career
    He currently holds an Associate Professor position at Guangdong Medical University, demonstrating academic growth and recognition. Prior engagements at prominent institutions like the Shenzhen PKU-HKUST Medical Center further underscore his institutional reputation.

  • Independent Research Grants as PI
    Dr. Zhang has secured multiple national and regional research projects, such as:

    • NSFC Youth Science Fund (2024–2026)

    • Guangdong Basic and Applied Basic Research Foundation (2022–2025)

    • China Postdoctoral Science Foundation (2020–2022)
      This shows his ability to attract competitive funding and lead research independently.

  • Strong Publication Record in High-Impact Journals
    Notable publications include:

    • EMBO Molecular Medicine (impactful and reputed in biomedical research)

    • Frontiers in Cell and Developmental Biology

    • Journal of Cellular Physiology

    • Toxicology
      These reflect both quality and diversity in research topics including oocyte maturation, spindle checkpoint regulation, cancer cell biology, and blastocyst complementation.

🎓 Education

Dr. Zhang embarked on his academic journey at Northeast Agricultural University (2009–2013), where he earned a degree in Biological Sciences. He then pursued a PhD in Developmental Biology at the Institute of Zoology, Chinese Academy of Sciences (2013–2019), where he delved into molecular mechanisms guiding embryonic and reproductive development in animals.

🧪 Experience

Following his doctoral studies, Dr. Zhang expanded his research horizon through prestigious postdoctoral work (2013–2019) at the Institute of Zoology, Chinese Academy of Sciences. He later contributed as a researcher at the Shenzhen Peking University–Hong Kong University of Science and Technology Medical Center (2020–2022). Since July 2022, he has held a faculty position as Associate Professor at Guangdong Medical University, where he actively leads independent research projects in developmental biology and gene regulation.

🔬 Research Interests On Biology

Dr. Zhang’s research interests revolve around the molecular regulation of oocyte maturation, chromatin accessibility, meiotic progression, and blastocyst complementation. He is also passionate about the development of gene-edited animal models for studying neurodegenerative and metabolic diseases. His focus on GPER1 gene editing, Fosl2 mechanisms, and spindle checkpoint regulation underpins his impactful contributions to reproductive and regenerative medicine.

🏆 Awards

Dr. Zhang has received multiple national and regional grants as Principal Investigator, reflecting his scientific excellence and innovation. These include:

  • NSFC Youth Science Fund Project (2024–2026) on Fosl2 mechanisms

  • GDBR Youth Science Fund Project (2022–2025) on CyclinB2/CDK1 regulation

  • China Postdoctoral Science Foundation General Fund (2020–2022) for CRISPR/Cas9-based GPER1 knockout pig models

📚 Publications

Dr. Zhang has published high-impact papers in leading scientific journals. Below is a list of selected publications with full citation and links:

  1. Zhang H-Y, et al. Rescuing ocular development in an anophthalmic pig by blastocyst complementation. EMBO Molecular Medicine, 2018, 10(12): e8861.

    Cited by: 120 articles

  2. Zhang H-Y, Li J, Ouyang Y-C, et al. Cell Division Cycle 5-Like Regulates Metaphase-to-Anaphase Transition in Meiotic Oocyte. Frontiers in Cell and Developmental Biology, 2021, 9: 671685.

    Cited by: 47 articles

  3. Guan Y-T, Zhang C, Zhang H-Y, et al. Primary cilia: Structure, dynamics, and roles in cancer cells and tumor microenvironment. Journal of Cellular Physiology, 2023, 238(8): 1788–1807.

    Cited by: 15 articles

  4. Chen H, Gong S, Zhang H-Y, et al. From the regulatory mechanism of TFEB to its therapeutic implications. Cell Death Discovery, 2024, 10(1): Full Text.

    Cited by: 5 articles

  5. Zhang H-Y, Ouyang Y-C, Li J, et al. Gefitinib reduces oocyte quality by disturbing meiotic progression. Toxicology, 2021, 452: 152705.

    Cited by: 32 articles

🧾 Conclusion

With a strong foundation in molecular biology and developmental genetics, Dr. Hongyong Zhang exemplifies scientific excellence through his research, mentorship, and academic service. His pioneering work in oocyte biology, chromatin regulation, and gene editing has earned him a reputable place in the field, along with a robust publication record and competitive research funding. His dedication makes him a deserving nominee for any prestigious research award in biomedical sciences.

Xiuqin Bao | Biology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Xiuqin Bao | Biology | Best Researcher Award

Guangdong Women and Children Hospital | China

Dr. Xiuqin Bao is a dedicated Associate Research Fellow specializing in medical genetics, with a strong background in epigenetic regulation and prenatal diagnostics. Her work focuses on developing innovative genetic therapies, particularly for blood disorders like β-thalassemia. She has co-authored multiple high-impact publications and contributed to significant research grants.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Strong Research Background:

    • Ph.D. in Genetics with a high GPA (3.8/4.0).

    • Focused research on β-thalassemia and γ-globin reactivation, a critical area in genetic medicine.

    • Published 8 papers, including multiple first/co-first author contributions in high-impact journals (IF 9.4–11.025).

  • Innovative Contributions:

    • Developed CRISPR-Cas9 editing strategies for HBG2 promoter activation.

    • Identified DNA methylation biomarkers for γ-globin reactivation.

    • Co-invented a ddPCR-based assay for α-globin gene CNV detection (patent holder).

  • Research Leadership & Funding:

    • Secured two major funded projects as Principal Investigator (total ¥350K).

    • Contributed to a ¥5.4M National Key R&D Program.

    • Recognized as Guangdong Outstanding Young Scholar (2024–2027).

  • Clinical & Technical Expertise:

    • Handles 500+ clinical cases annually with a 99% diagnostic accuracy.

    • Expertise in CRISPR, omics, and bioinformatics.

Education 🎓

Dr. Bao earned her Ph.D. and M.S. in Genetics from Southern Medical University (2015–2020), where she investigated the epigenetic regulation of γ-globin reactivation in β-thalassemia. She also holds a B.S. in Biopharmaceuticals (2011–2015) and was recognized with multiple academic excellence awards, including the First-Class Academic Scholarship.

Experience 💼

Currently serving as a Clinical Laboratory Technologist at Guangdong Women and Children Hospital, Dr. Bao conducts advanced prenatal diagnostic testing for thalassemia. She previously led epigenetic research projects as a Doctoral Researcher at Southern Medical University, contributing to groundbreaking discoveries in DNA methylation biomarkers and CRISPR-Cas9 editing for γ-globin activation.

Research Interests On Biology 🔬

Dr. Bao’s primary research focus is on the genetic and epigenetic mechanisms underlying hereditary blood disorders. She is particularly interested in using CRISPR gene-editing technology to reactivate fetal hemoglobin, offering potential therapeutic strategies for β-thalassemia. Her work also extends to biomarker discovery for precision medicine applications.

Awards 🏆

Dr. Bao has received several prestigious awards, including:

  • Guangdong Outstanding Young Scholar (2024–2027)
  • First-Class Academic Scholarships (2016, 2017, 2022)
  • Outstanding Communist Party Member (2018–2019) Her contributions to medical genetics have been recognized nationally and internationally.

Publications 📚

Dr. Bao has authored numerous high-impact publications, including:

  • “Activation of γ-globin expression by LncRNA-mediated ERF promoter hypermethylation in β-thalassemia”​

    • Co-authors: Yuanyi Gao, Zhongju Wang, Yuhua Ye, Diyu Chen, Yangjin Zuo, Cunyou Zhao, Xiangmin Xu​

    • Publication Year: 2024​

  • “DNA methylation patterns of β-globin cluster in β-thalassemia patients”​

    • Co-authors: Yangjin Zuo, Diyu Chen, Cunyou Zhao​

    • Publication Year: 2020​

    • Citations: 7​

  • “Abnormal hemoglobin anti-Lepore Hong Kong compound with β⁰-thalassemia ameliorate thalassemia severity when co-inherited with α-thalassemia”​

    • Co-authors: Jicheng Wang, Danqing Qin, Cuize Yao, Jie Liang, Kailing Liang, Li Du​

    • Publication Year: 2024​

  • “Severe fetal anemia and hydrops fetalis associated with compound heterozygosity for Hb Zurich-Albisrieden (HBA2:c.178G>C) and Hb Quong Sze (HBA2:c.377T>C)”​

    • Co-authors: Li Du, Wei He, Danqing Qin, Jicheng Wang, Ying Xiong, Xiaomei Shi, Hongke Ding, Cuize Yao, Jing Wu​

    • Publication Year: 2021​

  • “Identification and characterization of CHD4-associated eRNA as a novel modulator of fetal hemoglobin levels in β-thalassemia”

    • Co-authors: Not specified​

    • Publication Year: 2024​

    • Citations: 1​

  • “Two novel deletion mutations in β-globin gene cause β-thalassemia trait in two Chinese families”​

    • Co-authors: Danqing Qin, Jicheng Wang, Jing Chen, Cuize Yao, Jie Liang, Kailing Liang, Yixia Wang, Yousheng Wang, Li Du, Aihua Yin​

    • Publication Year: 2023​

  • “Different effects of anxiety and avoidance dimensions of attachment on interpersonal trust: A multilevel meta-analysis”​

    • Co-authors: Song Li, Yaoyao Zhang, Qingting Tang, Xu Chen​

    • Publication Year: 2022​

Conclusion 📝

Dr. Xiuqin Bao is a leading researcher in medical genetics, whose work in epigenetic modulation and gene therapy holds great promise for the future of hereditary blood disorder treatments. Through her extensive research, publications, and clinical expertise, she continues to contribute significantly to the advancement of genetic medicine.

Yiyao Cao | Biology | Best Researcher Award

Posted on by Forensic Scientist

Prof. Dr. Yiyao Cao | Biology | Best Researcher Award

Prof. Dr | Zhejiang Provincial Center for Disease Control and Prevention | China

Prof. Dr. Yiyao Cao is a distinguished expert in radiation detection and dose assessment, serving at the Zhejiang Provincial Center for Disease Control and Prevention. With a Doctor of Medicine (M.D.) degree and extensive expertise in radiation protection, Dr. Cao is a dedicated researcher addressing public concerns related to nuclear safety and environmental health. Her contributions have significantly advanced our understanding of the health implications of nuclear power operations.

Profile

Scopus

Strengths for the Awards

  • Specialized Research Focus: Dr. Cao’s expertise in radiation detection and dose assessment, coupled with her significant contribution to assessing radioactivity levels (Tritium and Carbon-14), demonstrates a niche and impactful research domain.
  • Research Output:
    • Published impactful research: The study on Tritium and Carbon-14 around San’ao Nuclear Power Plant highlights public health relevance.
    • Indexed Journals: Contributions to SCI-indexed journals signify the quality of her publications.
  • Innovative and Public Health Relevance:
    • The research addresses public concerns regarding nuclear power plant emissions, showcasing practical applications of findings.
    • Demonstrates a commitment to safeguarding community health through scientific evaluation.
  • Educational and Professional Credentials:
    • Holding an M.D. and leading research projects at the Zhejiang Provincial Center for Disease Control and Prevention indicate her academic and professional caliber.

Education 🎓

Dr. Cao earned her Doctor of Medicine (M.D.) degree, specializing in radiation detection and dose assessment. Her rigorous academic background has laid a strong foundation for her impactful research and innovations in radiation protection and nuclear safety.

Experience 🏢

Prof. Dr. Cao has accumulated years of professional expertise in radiation detection and public health. She has conducted critical studies to evaluate tritium and carbon-14 levels in food near nuclear power plants, ensuring environmental safety. Her leadership at the Zhejiang Provincial CDC reflects her commitment to advancing public health through research and practical applications.

Research Interests On Biology🔬

Dr. Cao focuses on radiation detection and dose assessment, with a special interest in environmental safety related to nuclear power operations. Her work assesses the risks posed by tritium and carbon-14, addressing public health concerns and guiding regulatory standards.

Awards 🏆

Award Nomination: Best Researcher Award
Dr. Cao has been nominated for her groundbreaking contributions to radiation protection research. Her studies have influenced health risk assessments and safety protocols in nuclear power operations.

Publications 📚

  • Efficient separation of Th(IV) from highly acidic solution by microporous resin materials containing two novel phenanthroline phosphonates
    Authors: Xu, L., Zou, Y., Dai, G., Pu, N., Zou, H.
    Year: 2025
    Citations: 0
  • Radon concentration and related employees’ chromosome aberration and micronuclei in subways in a city of Zhejiang Province
    Authors: Xuan, Z., Huang, X., Lai, Z., Zhang, D., Nie, J.
    Year: 2024
    Citations: 0
  • Development and application of UPLC-Q-Orbitrap HRMS methods for the determination of eight metabolites of p-chloronitrobenzene in human urine
    Authors: Wang, P., Xu, Q., Zou, H., Wang, J., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination and human health risk assessment of TFWT, OBT and carbon-14 in seafood around Qinshan Nuclear Power Plant
    Authors: Ma, X., Cao, Y., Zheng, T., Ren, H.
    Year: 2024
    Citations: 1
  • Manganese dioxide decorated kiwi peel powder for efficient removal of lead from aqueous solutions, blood and Traditional Chinese Medicine extracts
    Authors: Gong, H., Cao, Y., Zeng, W., Kai, G., Qian, J.
    Year: 2024
    Citations: 0
  • Achievements in Preparation of Cyclodextrin–Based Porous Materials for Removal of Pollutants
    Authors: Bao, K., Zhang, A., Cao, Y., Xu, L.
    Year: 2024
    Citations: 1
  • Recent progresses in analytical method development for 210Pb in environmental and biological samples
    Authors: Ren, H., Gong, X., Zhou, L., Wang, P., Cao, Y.
    Year: 2024
    Citations: 0
  • Determination of carbon-14 in marine biota using oxidation combustion and gel suspension liquid scintillation counting
    Authors: Cao, Y., Qian, Y., Ren, H., Xie, Y., Ji, Y.
    Year: 2024
    Citations: 2
  • Establishment of OBT/TFWT dataset in seafood in Zhejiang province, China
    Authors: Gong, X., Huang, W., Cao, Y., Wang, P., Ren, H.
    Year: 2024
    Citations: 0
  • Model prediction of radioactivity levels in the environment and food around the world’s first AP 1000 nuclear power unit
    Authors: Wang, P., Huang, W., Zou, H., Xuan, Z., Cao, Y.
    Year: 2024
    Citations: 0

Conclusion ✅

Prof. Dr. Yiyao Cao’s work exemplifies dedication to public health and environmental safety. Through her expertise in radiation detection and dose assessment, she contributes to the well-being of communities and sets high standards in research and practice. Her achievements underscore her suitability for the Best Researcher Award.